Search results for: COVID-19 Research
Filter search results
OHE Lunchtime Seminar and Webinar: The UK Biotech Sector and Brexit: Past Performance and Future Prospects
2 November 2017, 12:00am
…in the LSE’s Department of Management, LSE (1991-2015). Dr. Michael Hopkins is a Senior Lecturer and Director of Research at SPRU – the Science Policy Research Unit, in the School…
OHE Lunchtime Seminar: Providing Health Care to NHS Patients: How Much Does Ownership Matter?
28 February 2018, 12:00am
…Cambridge: the Cambridge Centre for Health Services Research. His health economics research interests include the role of economic incentives in health care, the impact of private sector provision, and the…
Valuing Health at the End of Life: A Review of Stated Preference Studies in the Social Sciences Literature
9 April 2018
…a long-standing research collaboration between OHE and Professors Aki Tsuchiya and Allan Wailoo from the University of Sheffield’s School of Health and Related Research. Related publications include: Shah, K.K., Tsuchiya,…
OHE Lunchtime Seminar: Health Years in Total (HYT): A New Health Objective Function for Cost-effectiveness Analysis
23 July 2019, 11:00pm
…Basu, PhD, MS, is a health economist and a statistician specializes in research on comparative and cost effectiveness analyses, causal inference methods, program evaluation, and outcomes research. Anirban is Director…
The World Needs New Antibiotics. A Proposed US Program to Develop Them Offers a High Pay-Off
16 November 2022
…Benefit: Cost Ratio 10-Year $11.7 bn 518,000 19.5 million 310.6 billion 27:1 30-Year $38.9 bn 9,933,000 374.5 million 4,874.2 billion 125:1 We expect other G7 and EU countries to pay…
Anita Charlesworth
18 January 2023
…and Social Research Council (ESRC), a member of DWP’s Labour Market Advisory Board, the Health and Social Care Select Committee’s expert panel and the Office of Budget Responsibility (OBR) Advisory…
Legal Barriers to the Better Use of Health Data to Deliver Pharmaceutical Innovation
1 December 2018
The proliferation of health data in our ever more digitalised world of health care creates opportunities for better research around – and delivery of – pharmaceutical innovation. However, these opportunities…
Access to Orphan Drugs in the EU
21 October 2010
…research conducted across countries at the European and international levels. Moreover, in order to ensure timely access to new OMPs, much of this research will need to be done after…
Pharmaceutical Innovation: Recent Trends, Future Prospects
1 October 1983
…morbidity still remaining in the community have provided a powerful incentive to continued investigation of the causes of, and potential solutions to, disease. As a consequence research expenditures have maintained…